CALCIUM GLUCONATE 10 %w/v, 1 Grams Solution for Injection
Nchi: Ayalandi
Lugha: Kiingereza
Chanzo: HPRA (Health Products Regulatory Authority)
Tabia za bidhaa
(SPC)
06-06-2024
Hati zingine za bidhaa hii hazipatikani kwa sasa, unaweza kutuma ombi kwa huduma ya wateja wetu na tutakuarifu mara tu tutakapopata.
Tuma ombi.
Tuma ombi.
Viambatanisho vya kazi:
CALCIUM GLUCONATE
Inapatikana kutoka:
Mercury Pharmaceuticals (Ireland) Ltd
INN (Jina la Kimataifa):
CALCIUM GLUCONATE
Kipimo:
10 %w/v, 1 Grams
Dawa fomu:
Solution for Injection
Idhini hali ya:
Withdrawn
Idhini ya tarehe:
2008-06-23
Tabia za bidhaa
PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Calcium Gluconate Injection BP 10% w/v, 10ml
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 10 ml of solution contains 2.25 millimoles of Ca
2+
as calcium gluconate (975mg/10ml).
Each ml of solution contains 0.225 millimoles of Ca
2+
as calcium gluconate (95.7 mg/ml).
For excipients, see 6.1.
3 PHARMACEUTICAL FORM
Solution for injection
Clear, colourless, sterile solution.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Parenteral administration is indicated where the pharmacological action of a high calcium ion concentration is
required, as in acute hypocalcaemia and hypocalcaemic tetany.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
For intravenous or intramuscular injection.
Adults: The usual dose is 5 - 10ml (1.125 - 2.25 mmol or 2.25 - 4.5 mEq Ca
++
) by slow I.V. injection or by deep
I.M. injection into the gluteal region. The dose can be repeated daily or every second day as required.
Children: The usual dose is 2.5 - 5.0ml (0.562 - 1.125 mmol or 1.125 - 2.25 mEq Ca
++
) by slow I.V. injection. The
intramuscular route is not recommended for children.
Elderly: As per adults, but elderly patients should be carefully supervised (See Warnings and Precautions).
4.3 CONTRAINDICATIONS
Use in patients with hypercalcaemia and hypercalciuria (e.g. in hyperparathyroidism, hypervitaminosis D, neoplastic
disease with decalcification of bone, immobilisation osteoporosis, sarcodiosis).
Use in patients with renal insufficiency.
Use in patients with milk-alkali syndrome.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Calcium salts should be used with caution in patients with impaired renal function, or with nephrocalcinosis, or in
the elderly.
Patients receiving calcium salts should be monitored, carefully, to ensure main
Soma hati kamili
